Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Coadministration of Chemokine Receptor Antagonists with Morphine Potentiates Morphine's Analgesic Effect on Incisional Pain in Rats.

Inan S, Eisenstein TK, Watson MN, Doura M, Meissler JJ, Tallarida CS, Chen X, Geller EB, Rawls SM, Cowan A, Adler MW.

J Pharmacol Exp Ther. 2018 Dec;367(3):433-441. doi: 10.1124/jpet.118.252890. Epub 2018 Sep 24.

PMID:
30249618
2.

Responsive neurostimulation: Review of clinical trials and insights into focal epilepsy.

Geller EB.

Epilepsy Behav. 2018 Nov;88S:11-20. doi: 10.1016/j.yebeh.2018.06.042. Epub 2018 Sep 20. Review.

PMID:
30243756
3.

Brain-responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy.

Geller EB, Skarpaas TL, Gross RE, Goodman RR, Barkley GL, Bazil CW, Berg MJ, Bergey GK, Cash SS, Cole AJ, Duckrow RB, Edwards JC, Eisenschenk S, Fessler J, Fountain NB, Goldman AM, Gwinn RP, Heck C, Herekar A, Hirsch LJ, Jobst BC, King-Stephens D, Labar DR, Leiphart JW, Marsh WR, Meador KJ, Mizrahi EM, Murro AM, Nair DR, Noe KH, Park YD, Rutecki PA, Salanova V, Sheth RD, Shields DC, Skidmore C, Smith MC, Spencer DC, Srinivasan S, Tatum W, Van Ness PC, Vossler DG, Wharen RE Jr, Worrell GA, Yoshor D, Zimmerman RS, Cicora K, Sun FT, Morrell MJ.

Epilepsia. 2017 Jun;58(6):994-1004. doi: 10.1111/epi.13740. Epub 2017 Apr 11.

4.

Brain-responsive neurostimulation in patients with medically intractable seizures arising from eloquent and other neocortical areas.

Jobst BC, Kapur R, Barkley GL, Bazil CW, Berg MJ, Bergey GK, Boggs JG, Cash SS, Cole AJ, Duchowny MS, Duckrow RB, Edwards JC, Eisenschenk S, Fessler AJ, Fountain NB, Geller EB, Goldman AM, Goodman RR, Gross RE, Gwinn RP, Heck C, Herekar AA, Hirsch LJ, King-Stephens D, Labar DR, Marsh WR, Meador KJ, Miller I, Mizrahi EM, Murro AM, Nair DR, Noe KH, Olejniczak PW, Park YD, Rutecki P, Salanova V, Sheth RD, Skidmore C, Smith MC, Spencer DC, Srinivasan S, Tatum W, Van Ness P, Vossler DG, Wharen RE Jr, Worrell GA, Yoshor D, Zimmerman RS, Skarpaas TL, Morrell MJ.

Epilepsia. 2017 Jun;58(6):1005-1014. doi: 10.1111/epi.13739. Epub 2017 Apr 7.

5.

Heroin inhibits HIV-restriction miRNAs and enhances HIV infection of macrophages.

Wang X, Ma TC, Li JL, Zhou Y, Geller EB, Adler MW, Peng JS, Zhou W, Zhou DJ, Ho WZ.

Front Microbiol. 2015 Nov 4;6:1230. doi: 10.3389/fmicb.2015.01230. eCollection 2015.

6.

Lateralization of mesial temporal lobe epilepsy with chronic ambulatory electrocorticography.

King-Stephens D, Mirro E, Weber PB, Laxer KD, Van Ness PC, Salanova V, Spencer DC, Heck CN, Goldman A, Jobst B, Shields DC, Bergey GK, Eisenschenk S, Worrell GA, Rossi MA, Gross RE, Cole AJ, Sperling MR, Nair DR, Gwinn RP, Park YD, Rutecki PA, Fountain NB, Wharen RE, Hirsch LJ, Miller IO, Barkley GL, Edwards JC, Geller EB, Berg MJ, Sadler TL, Sun FT, Morrell MJ.

Epilepsia. 2015 Jun;56(6):959-67. doi: 10.1111/epi.13010. Epub 2015 May 19.

7.

De novo mutations in epileptic encephalopathies.

Epi4K Consortium; Epilepsy Phenome/Genome Project, Allen AS, Berkovic SF, Cossette P, Delanty N, Dlugos D, Eichler EE, Epstein MP, Glauser T, Goldstein DB, Han Y, Heinzen EL, Hitomi Y, Howell KB, Johnson MR, Kuzniecky R, Lowenstein DH, Lu YF, Madou MR, Marson AG, Mefford HC, Esmaeeli Nieh S, O'Brien TJ, Ottman R, Petrovski S, Poduri A, Ruzzo EK, Scheffer IE, Sherr EH, Yuskaitis CJ, Abou-Khalil B, Alldredge BK, Bautista JF, Berkovic SF, Boro A, Cascino GD, Consalvo D, Crumrine P, Devinsky O, Dlugos D, Epstein MP, Fiol M, Fountain NB, French J, Friedman D, Geller EB, Glauser T, Glynn S, Haut SR, Hayward J, Helmers SL, Joshi S, Kanner A, Kirsch HE, Knowlton RC, Kossoff EH, Kuperman R, Kuzniecky R, Lowenstein DH, McGuire SM, Motika PV, Novotny EJ, Ottman R, Paolicchi JM, Parent JM, Park K, Poduri A, Scheffer IE, Shellhaas RA, Sherr EH, Shih JJ, Singh R, Sirven J, Smith MC, Sullivan J, Lin Thio L, Venkat A, Vining EP, Von Allmen GK, Weisenberg JL, Widdess-Walsh P, Winawer MR.

Nature. 2013 Sep 12;501(7466):217-21. doi: 10.1038/nature12439. Epub 2013 Aug 11.

8.

Response.

Carlson C, Elliott RE, Devinsky O, Geller EB, Bollo RJ, Barr WB, Doyle WK.

J Neurosurg. 2013 Aug;119(2):258-60. doi: 10.3171/jns.2013.119.2.2. No abstract available.

PMID:
23905717
9.

Anterior temporal lobectomy with amygdalohippocampectomy for mesial temporal sclerosis: predictors of long-term seizure control.

Elliott RE, Bollo RJ, Berliner JL, Silverberg A, Carlson C, Geller EB, Barr WB, Devinsky O, Doyle WK.

J Neurosurg. 2013 Aug;119(2):261-72. doi: 10.3171/2013.4.JNS121829. Epub 2013 May 24.

PMID:
23706057
10.

Differential antinociceptive effects of buprenorphine and methadone in the presence of HIV-gp120.

Palma J, Cowan A, Geller EB, Adler MW, Benamar K.

Drug Alcohol Depend. 2011 Nov 1;118(2-3):497-9. doi: 10.1016/j.drugalcdep.2011.04.010. Epub 2011 May 19.

11.

The effect of gp120 on morphine's antinociceptive and neurophysiological actions.

Chen X, Kirby LG, Palma J, Benamar K, Geller EB, Eisenstein TK, Adler MW.

Brain Behav Immun. 2011 Oct;25(7):1434-43. doi: 10.1016/j.bbi.2011.04.014. Epub 2011 May 5.

12.

Impact of failed intracranial epilepsy surgery on the effectiveness of subsequent vagus nerve stimulation.

Elliott RE, Morsi A, Geller EB, Carlson CC, Devinsky O, Doyle WK.

Neurosurgery. 2011 Dec;69(6):1210-7. doi: 10.1227/NEU.0b013e3182230ae3.

PMID:
21558973
13.

Vagus nerve stimulation for children with treatment-resistant epilepsy: a consecutive series of 141 cases.

Elliott RE, Rodgers SD, Bassani L, Morsi A, Geller EB, Carlson C, Devinsky O, Doyle WK.

J Neurosurg Pediatr. 2011 May;7(5):491-500. doi: 10.3171/2011.2.PEDS10505.

PMID:
21529189
14.

Analgesic efficacy of buprenorphine in the presence of high levels of SDF-1α/CXCL12 in the brain.

Benamar K, Palma J, Cowan A, Geller EB, Adler MW.

Drug Alcohol Depend. 2011 Apr 1;114(2-3):246-8. doi: 10.1016/j.drugalcdep.2010.08.015. Epub 2010 Nov 26.

15.

Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activity.

Zhao P, Sharir H, Kapur A, Cowan A, Geller EB, Adler MW, Seltzman HH, Reggio PH, Heynen-Genel S, Sauer M, Chung TD, Bai Y, Chen W, Caron MG, Barak LS, Abood ME.

Mol Pharmacol. 2010 Oct;78(4):560-8. doi: 10.1124/mol.110.066746. Epub 2010 Jul 22.

16.

Intrahypothalamic injection of the HIV-1 envelope glycoprotein induces fever via interaction with the chemokine system.

Benamar K, Addou S, Yondorf M, Geller EB, Eisenstein TK, Adler MW.

J Pharmacol Exp Ther. 2010 Feb;332(2):549-53. doi: 10.1124/jpet.109.160309. Epub 2009 Nov 11.

17.

Physiological evidence for interaction between the HIV-1 co-receptor CXCR4 and the cannabinoid system in the brain.

Benamar K, Yondorf M, Geller EB, Eisenstein TK, Adler MW.

Br J Pharmacol. 2009 Aug;157(7):1225-31. doi: 10.1111/j.1476-5381.2009.00285.x. Epub 2009 Jun 22.

18.

A new brain area affected by 3,4-methylenedioxymethamphetamine: A microdialysis-biotelemetry study.

Benamar K, Geller EB, Adler MW.

Eur J Pharmacol. 2008 Oct 31;596(1-3):84-8. doi: 10.1016/j.ejphar.2008.08.001. Epub 2008 Aug 13.

PMID:
18727928
19.

Elevated level of the proinflammatory chemokine, RANTES/CCL5, in the periaqueductal grey causes hyperalgesia in rats.

Benamar K, Geller EB, Adler MW.

Eur J Pharmacol. 2008 Sep 11;592(1-3):93-5. doi: 10.1016/j.ejphar.2008.07.009. Epub 2008 Jul 11.

PMID:
18656466
20.

Bi-directional heterologous desensitization between the major HIV-1 co-receptor CXCR4 and the kappa-opioid receptor.

Finley MJ, Chen X, Bardi G, Davey P, Geller EB, Zhang L, Adler MW, Rogers TJ.

J Neuroimmunol. 2008 Jul 15;197(2):114-23. doi: 10.1016/j.jneuroim.2008.04.021. Epub 2008 Jun 3.

21.

First in vivo evidence for a functional interaction between chemokine and cannabinoid systems in the brain.

Benamar K, Geller EB, Adler MW.

J Pharmacol Exp Ther. 2008 May;325(2):641-5. doi: 10.1124/jpet.107.135053. Epub 2008 Feb 15. Erratum in: J Pharmacol Exp Ther. 2008 Jun;325(3):1061.

22.

Deletion of mu-opioid receptor in mice alters the development of acute neuroinflammation.

Benamar K, Yondorf M, Barreto VT, Geller EB, Adler MW.

J Pharmacol Exp Ther. 2007 Dec;323(3):990-4. Epub 2007 Sep 26.

23.

AAN Board of Directors recommends formation of a companion association to establish a political action committee.

Geller EB.

Neurology. 2007 Sep 11;69(11):1192-3; author reply 1193. No abstract available.

PMID:
17846421
24.
25.

A novel role of cannabinoids: implication in the fever induced by bacterial lipopolysaccharide.

Benamar K, Yondorf M, Meissler JJ, Geller EB, Tallarida RJ, Eisenstein TK, Adler MW.

J Pharmacol Exp Ther. 2007 Mar;320(3):1127-33. Epub 2006 Dec 28.

26.
27.

Rapid heterologous desensitization of antinociceptive activity between mu or delta opioid receptors and chemokine receptors in rats.

Chen X, Geller EB, Rogers TJ, Adler MW.

Drug Alcohol Depend. 2007 Apr 17;88(1):36-41. Epub 2006 Oct 17.

28.

Viewing chemokines as a third major system of communication in the brain.

Adler MW, Geller EB, Chen X, Rogers TJ.

AAPS J. 2006 Jan 6;7(4):E865-70. Review.

29.

The dynamic relationship between mu and kappa opioid receptors in body temperature regulation.

Chen X, McClatchy DB, Geller EB, Tallarida RJ, Adler MW.

Life Sci. 2005 Dec 12;78(4):329-33. Epub 2005 Oct 28.

PMID:
16257420
30.

Unresponsiveness of mu-opioid receptor knockout mice to lipopolysaccharide-induced fever.

Benamar K, McMenamin M, Geller EB, Chung YG, Pintar JE, Adler MW.

Br J Pharmacol. 2005 Apr;144(8):1029-31.

31.

Intrahypothalamic injection of deltorphin-II alters body temperature in rats.

Benamar K, Rawls SM, Geller EB, Adler MW.

Brain Res. 2004 Sep 3;1019(1-2):22-7.

PMID:
15306234
32.

GABAA receptors modulate cannabinoid-evoked hypothermia.

Rawls SM, Tallarida RJ, Kon DA, Geller EB, Adler MW.

Pharmacol Biochem Behav. 2004 May;78(1):83-91.

PMID:
15159137
33.

Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model.

Ni X, Geller EB, Eppihimer MJ, Eisenstein TK, Adler MW, Tuma RF.

Mult Scler. 2004 Apr;10(2):158-64.

PMID:
15124761
35.

Role of the nitric-oxide synthase isoforms during morphine-induced hyperthermia in rats.

Benamar K, Yondorf MZ, Kon D, Geller EB, Adler MW.

J Pharmacol Exp Ther. 2003 Oct;307(1):219-22. Epub 2003 Sep 3.

36.

NMDA receptors modulate morphine-induced hyperthermia.

Rawls SM, Adler MW, Gaughan JP, Baron A, Geller EB, Cowan A.

Brain Res. 2003 Sep 12;984(1-2):76-83.

PMID:
12932841
38.

Role of the nitric oxide pathway in kappa-opioid-induced hypothermia in rats.

Benamar K, Geller EB, Adler MW.

J Pharmacol Exp Ther. 2002 Oct;303(1):375-8.

39.

Sigma sites mediate DTG-evoked hypothermia in rats.

Rawls SM, Baron DA, Geller EB, Adler MW.

Pharmacol Biochem Behav. 2002 Nov;73(4):779-86.

PMID:
12213522
40.

Abrupt or precipitated withdrawal from morphine induces immunosuppression.

Rahim RT, Adler MW, Meissler JJ Jr, Cowan A, Rogers TJ, Geller EB, Eisenstein TK.

J Neuroimmunol. 2002 Jun;127(1-2):88-95.

PMID:
12044979
42.

Effect of a mu-opioid receptor-selective antagonist on interleukin-6 fever.

Benamar K, Geller EB, Adler MW.

Life Sci. 2002 Mar 22;70(18):2139-45.

PMID:
12002806
43.

Administration of mu-, kappa- or delta2-receptor agonists via osmotic minipumps suppresses murine splenic antibody responses.

Rahim RT, Meissler JJ Jr, Cowan A, Rogers TJ, Geller EB, Gaughan J, Adler MW, Eisenstein TK.

Int Immunopharmacol. 2001 Oct;1(11):2001-9.

PMID:
11606031
44.

Possible mechanism of hypothermia induced by intracerebroventricular injection of orphanin FQ/nociceptin.

Chen X, McClatchy DB, Geller EB, Liu-Chen L, Tallarida RJ, Adler MW.

Brain Res. 2001 Jun 22;904(2):252-8.

PMID:
11406123
45.

Effect of central and peripheral administration of a nitric oxide synthase inhibitor on morphine hyperthermia in rats.

Benamar K, Xin L, Geller EB, Adler MW.

Brain Res. 2001 Mar 16;894(2):266-73.

PMID:
11251200
46.

Blockade of lipopolysaccharide-induced fever by a mu-opioid receptor-selective antagonist in rats.

Benamar K, Xin L, Geller EB, Adler MW.

Eur J Pharmacol. 2000 Aug 4;401(2):161-5.

PMID:
10924921
47.

Morphine increases susceptibility to oral Salmonella typhimurium infection.

MacFarlane AS, Peng X, Meissler JJ Jr, Rogers TJ, Geller EB, Adler MW, Eisenstein TK.

J Infect Dis. 2000 Apr;181(4):1350-8. Epub 2000 Apr 13.

PMID:
10762566
48.

Effect of mu-selective opioid antagonists on MIP-1 beta and IL-1 beta-induced fever.

Handler CM, Price RW, Geller EB, Adler MW.

Ann N Y Acad Sci. 1998 Sep 29;856:270-3. No abstract available.

PMID:
9917888
49.
50.

Effect of a mu-selective opioid antagonist on CCK-8-induced changes in thermoregulation in the rat.

Ghosh S, Handler CM, Geller EB, Adler MW.

Pharmacol Biochem Behav. 1998 Jan;59(1):261-4.

PMID:
9443564

Supplemental Content

Loading ...
Support Center